Concordia fights rare CMA search warrant

Drugmaker Concordia is fighting a search warrant that the UK’s Competition and Markets Authority obtained as part of the antitrust enforcer’s hydrocortisone pay-for-delay investigation.


Get unlimited access to all Global Competition Review content